Tabugara, Ayessa A.

HRN: 38-34-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
CEFTRIAXONE 1G (VIAL)
12/28/2025
12/28/2025
IV
1.2g
Now
TBI, Multiple Abrasions
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines